CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 3, May/June 2014
AFRICA
113
11. Bae SH, Lee J, Roh KH, Kim J. Platelet activation in patients with
diabetic retinopathy.
Korean J Ophthalmol
2003;
17
: 140–144.
12. Brownlee M. Biochemistry and molecular cell biology of diabetic
complications.
Nature
2001;
414
: 813–820.
13. Kitada S, Otsuka Y, Kokubu N,
et al.
Post-load hyperglycemia as an
important predictor of long-term adverse cardiac events after acute
myocardial infarction: a scientific study.
Cardiovasc Diabetol
2010;
9
: 75.
14. Nishimura R, Nakagami T, Sone H, Ohashi Y, Tajima N. Relationship
between hemoglobin A1c and cardiovascular disease in mild-to-moder-
ate hypercholesterolemic Japanese individuals: subanalysis of a large-
scale randomized controlled trial.
Cardiovasc Diabetol
2011;
10
: 58.
15. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and
causes of death in the WHO Multinational Study of Vascular Disease in
Diabetes.
Diabetologia
2001;
44
(Suppl 2): S14–21.
16. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in
diabetic subjects.
Br Med J
1990;
301
: 92–95.
17. Prevalence of unrecognized silent myocardial ischemia and its associa-
tion with atherosclerotic risk factors in noninsulin-dependent diabetes
mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD)
Group.
Am J Cardiol
1997;
79
: 134–139.
18. Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The
relationship between glycemic control and platelet activity in type 2
diabetes mellitus.
J Diabetes Complicat
2009;
23
: 89–94.
19. Senaran H, Ileri M, Altinbas A,
et al
. Thrombopoietin and mean platelet
volume in coronary artery disease.
Clin Cardiol
2001;
24
: 405–408.
20. Thomas GS, Miyamoto MI, Morello AP, 3rd,
et al
. Technetium 99m
sestamibi myocardial perfusion imaging predicts clinical outcome
in the community outpatient setting. The Nuclear Utility in the
Community (NUC) Study.
J Am Coll Cardiol
2004;
43
: 213–223.
21. Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I.
Impairment of coronary microvascular dilation in response to cold
pressor-induced sympathetic stimulation in type 2 diabetic patients
with abnormal stress thallium imaging.
Diabetes
2001;
50
: 1180–1185.
22. Djaberi R, Beishuizen ED, Pereira AM,
et al
. Non-invasive cardiac
imaging techniques and vascular tools for the assessment of cardio-
vascular disease in type 2 diabetes mellitus.
Diabetologia
2008;
51
:
1581–1593.
23. Endler G, Klimesch A, Sunder-Plassmann H,
et al
. Mean platelet
volume is an independent risk factor for myocardial infarction but not
for coronary artery disease.
Br J Haematol
2002;
117
: 399–404.
24. Coppinger JA, Cagney G, Toomey S,
et al.
Characterization of the
proteins released from activated platelets leads to localization of novel
platelet proteins in human atherosclerotic lesions.
Blood
2004;
103
:
2096–2104.
25. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogen-
esis.
J Clin Investigat
2005;
115
: 3378–3384.
26. Rao AK, Goldberg RE, Walsh PN. Platelet coagulant activities in
diabetes mellitus. Evidence for relationship between platelet coagulant
hyperactivity and platelet volume. J Lab Clin Med 1984;
103
: 82–92.
27. Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D.
Influence of platelet volume on the ability of prostacyclin to inhibit
platelet aggregation and the release reaction.
J Lab Clin Med
1985;
105
: 271–276.
28. Ault KA, Cannon CP, Mitchell J,
et al
. Platelet activation in patients
after an acute coronary syndrome: results from the TIMI-12 trial.
Thrombolysis in Myocardial Infarction.
J Am Coll Cardiol
1999;
33
:
634–639.
29. Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity
and prognosis in survivors of myocardial infarction.
New Engl J Med
1990;
322
: 1549–1554.
30. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet
volume in patients with metabolic syndrome and its relationship with
coronary artery disease.
Thromb Res
2007;
120
: 245–250.
31. Varol E, Akcay S, Ozaydin M, Erdogan D, Dogan A, Altinbas A. Mean
platelet volume is associated with insulin resistance in non-obese,
non-diabetic patients with coronary artery disease.
J Cardiol
2010;
56
:
154–158.
32. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects
with impaired fasting glucose.
Platelets
2006;
17
: 67–69.
33. Cay S, Biyikoglu F, Cihan G, Korkmaz S. Mean platelet volume in
the patients with cardiac syndrome X.
J Thromb thrombol
2005;
20
:
175–178.
34. Gokce M, Kaplan S, Tekelioglu Y, Erdogan T, Kucukosmanoglu M.
Platelet function disorder in patients with coronary slow flow.
Clin
Cardiol
2005;
28
: 145–148.
